Data / Form D filings / Third Arc Bio, Inc.
Third Arc Bio, Inc.: Form D filing
Third Arc Bio, Inc., a biotechnology company in Lower Gwynedd, PA, filed a Form D with the SEC in 2024. The latest, on August 1, 2024, reports $72.5 million sold of a $165 million offering to 32 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 727 NORRISTOWN ROAD, BLDG 8 SUITE 320, Lower Gwynedd, PA, 19002
- Phone
- (610) 731-6021
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2032467
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 1, 2024 | New notice | $164,999,939 | $72,499,974 | $92,499,965 | 32 | Jul 16, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Joseph Erhardt | Executive Officer | |
| Arjun Goyal | Director | |
| Otello Stampacchia | Director | |
| Peter Lebowitz | Executive Officer, Director | |
| Francesco Draetta | Director |
Other biotechnology companies in Pennsylvania that filed recently
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
Every Form D from the week of Jul 29, 2024 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Third Arc Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.